2019
DOI: 10.3390/genes10020092
|View full text |Cite
|
Sign up to set email alerts
|

RNA Modifications Modulate Activation of Innate Toll-Like Receptors

Abstract: Self/foreign discrimination by the innate immune system depends on receptors that identify molecular patterns as associated to pathogens. Among others, this group includes endosomal Toll-like receptors, among which Toll-like receptors (TLR) 3, 7, 8, and 13 recognize and discriminate mammalian from microbial, potentially pathogen-associated, RNA. One of the discriminatory principles is the recognition of endogenous RNA modifications. Previous work has identified a couple of RNA modifications that impede activat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
71
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 92 publications
(73 citation statements)
references
References 125 publications
(148 reference statements)
2
71
0
Order By: Relevance
“…Thus, the precise requirements for the second binding pocket and the true nature of any minimal TLR8 ligand remain unclear. Moreover, given the broad number of conceivable di- or trinucleotide ligands for the second binding pocket, it seems unlikely that such motifs are not contained in self RNA, or that they could all be rendered inactive by modifications such as pseudouridine or 2’O-methylation ( Freund et al., 2019 ). In addition, it is unclear which inhibitory modifications affect TLR8 activation and which inhibit upstream RNases.…”
Section: Main Textmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, the precise requirements for the second binding pocket and the true nature of any minimal TLR8 ligand remain unclear. Moreover, given the broad number of conceivable di- or trinucleotide ligands for the second binding pocket, it seems unlikely that such motifs are not contained in self RNA, or that they could all be rendered inactive by modifications such as pseudouridine or 2’O-methylation ( Freund et al., 2019 ). In addition, it is unclear which inhibitory modifications affect TLR8 activation and which inhibit upstream RNases.…”
Section: Main Textmentioning
confidence: 99%
“…In addition, it is unclear which inhibitory modifications affect TLR8 activation and which inhibit upstream RNases. 2’O-methylation is a known inhibitor of TLR8 (and TLR7) activity ( Freund et al., 2019 ) but also of upstream RNaseT2 and RNase2 ( Ostendorf et al., 2020 ). Conceivably, self RNA does not avoid immunorecognition in the classical sense but rather contains inhibitory motifs perhaps similar to those synthetically designed for TLR7 and TLR8 ( Schmitt et al., 2017 ) using 2’O-methylation, but further studies will be necessary to determine if these sequences have natural counterparts in our self RNA.…”
Section: Main Textmentioning
confidence: 99%
“…The technology used for the synthesis of these in vitro transcribed RNAs-predominantly using phage RNA polymerases (RNAPs)-is robust and well established for the large-scale production of synthetic RNA. However, it is also known that introduction of synthetic in vitro transcribed mRNAs into cells or animal models results in an immune response against the synthetic molecules (Weissman et al 2000;Karikó et al 2004;Akira et al 2006;Sahin et al 2014;Freund et al 2019). Such outcomes are undesirable in therapeutic applications in which an immune response is detrimental or unnecessary (for example, protein-replacement therapies).…”
Section: Introductionmentioning
confidence: 99%
“…Such outcomes are undesirable in therapeutic applications in which an immune response is detrimental or unnecessary (for example, protein-replacement therapies). Incorporation of modified nucleosides into synthetic mRNA mitigates the immune response to some extent by mimicking endogenous mRNAs (Karikó et al 2005;Durbin et al 2016;Pardi et al 2017;Richner et al 2017;Freund et al 2019). Another major stimulant of the immune response comes from contaminants present in the IVT reactions.…”
Section: Introductionmentioning
confidence: 99%
“…Such outcomes are undesirable in therapeutic applications in which an immune response is detrimental or unnecessary (for example, protein-replacement therapies). Incorporation of modified nucleosides into synthetic mRNA mitigates the immune response to some extent by mimicking endogenous mRNAs [4,[6][7][8][9]. Another major stimulant of the immune response comes from contaminants present in the in vitro transcription reactions.…”
Section: Introductionmentioning
confidence: 99%